Primis signals 8%–8.5% year-end balance sheet growth as it targets TCE north of 8.5% in a few quarters

Dr. Reddy’s outlines semaglutide relaunch in November 2026 and reiterates 6M-7M devices target

How Low Can Charter Communications Stock Go?

S&P 500, Dow Drop As Elevated Oil Prices Stoke Inflation Fears Ahead Of Fed Meeting Next Week — AAPL, AXP, CART, UBER In Focus

WSFS outlines 45%-50% deposit beta in current hiking cycle while targeting double-digit Walton Trust growth